loadpatents
name:-0.030634164810181
name:-0.055095911026001
name:-0.015974998474121
MUMM; John Patent Filings

MUMM; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for MUMM; John.The latest application filed is for "dual cytokine fusion proteins comprising il-10".

Company Profile
9.8.20
  • MUMM; John - Germantown MD
  • MUMM; John - Bethesda MD
  • MUMM; JOHN - GAITHERSBURG MD
  • Mumm; John - Los Altos Hills CA
  • Mumm; John - Woodside CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dual Cytokine Fusion Proteins Comprising Il-10
App 20220281935 - MUMM; John
2022-09-08
Dual Cytokine Fusion Proteins Comprising Il-10
App 20220275040 - MUMM; John
2022-09-01
Dual Cytokine Fusion Proteins Comprising Il-10
App 20220275039 - MUMM; John
2022-09-01
Dual Cytokine Fusion Proteins Comprising Il-10
App 20220267397 - MUMM; John
2022-08-25
Il-10 Variant Molecules And Methods For Treating Inflammatory Disease And Oncology
App 20220106373 - MUMM; John
2022-04-07
Dual cytokine fusion proteins comprising IL-10
Grant 11,292,822 - Mumm April 5, 2
2022-04-05
Dual Cytokine Fusion Proteins Comprising Il-10
App 20220017587 - MUMM; John
2022-01-20
Method Of Using Genetic Markers, Single Nucleotide Polymorphisms And/or Indels To Determine Responsiveness To Il-10 Or Il-10 Derivative Treatment
App 20210214782 - MUMM; John
2021-07-15
IL-10 variant molecules and methods of treating inflammatory disease
Grant 10,981,965 - Mumm April 20, 2
2021-04-20
IL-10 variant molecules conjugated with antibody variable domain regions
Grant 10,981,966 - Mumm April 20, 2
2021-04-20
Antibody-IL-10 fusion proteins
Grant 10,975,134 - Mumm April 13, 2
2021-04-13
Methods for treating malignant tumors with IL-10 variant conjugates
Grant 10,975,133 - Mumm April 13, 2
2021-04-13
Il-10 Variant Molecules And Methods For Treating Inflammatory Disease And Oncology
App 20210040168 - MUMM; John
2021-02-11
Il-10 Variant Molecules And Methods For Treating Inflammatory Disease And Oncology
App 20200399337 - MUMM; John
2020-12-24
Il-10 Variant Molecules And Methods For Treating Inflammatory Disease And Oncology
App 20200385436 - MUMM; John
2020-12-10
IL-10 Variant Molecules and Methods for Treating Inflammatory Disease and Oncology
App 20200385435 - MUMM; John
2020-12-10
Il-10 Variant Molecules And Methods Of Treating Inflammatory Disease And Oncology
App 20200385437 - MUMM; John
2020-12-10
Antibody variable domain regions fused to IL-10 variant molecules
Grant 10,858,412 - Mumm December 8, 2
2020-12-08
Il-10 Variant Molecules And Methods Of Treating Inflammatory Disease And Oncology
App 20200283488 - MUMM; John
2020-09-10
Methods For Selection And Expansion Of T Cells Expressing Pd-1
App 20200199567 - HANABUCHI; SHINO ;   et al.
2020-06-25
Bispecific Fusion Polypeptides And Methods Of Use Thereof
App 20190241659 - MUMM; JOHN ;   et al.
2019-08-08
Method of treating solid cancers with pegylated IL-10
Grant 8,865,652 - Oft , et al. October 21, 2
2014-10-21
Use Of Il-33 Antagonists To Treat Fibrotic Disease
App 20140212412 - RANKIN; ANDREW L. ;   et al.
2014-07-31
Use Of Il-33 Antagonists To Treat Fibrotic Diseases
App 20120263709 - Rankin; Andrew L. ;   et al.
2012-10-18
Use of Pegylated IL-10 to Treat Cancer
App 20110091419 - Oft; Martin ;   et al.
2011-04-21
Use Of Pegylated Il-10 To Treat Cancer
App 20090214471 - Oft; Martin ;   et al.
2009-08-27
Use of Pegylated IL-10 to Treat Cancer
App 20080081031 - Oft; Martin ;   et al.
2008-04-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed